“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Viridian Therapeutics, Inc
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridians expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. Viridians goal is to advance VRDN-001 as a potential best-in-class intravenous therapy followed by VRDN-003 as a potential first- and best-in-class subcutaneous therapy for the treatment of TED. In addition to its TED portfolio, Viridian is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and V...
| C-Level 5 | VP - Level17 |
| Director51 | Manager25 |
| Others67 | |
| Structure | Email Format |
|---|---|
| <f><last>@ |
|
| <first>.<l>@ |
John. |
| <first>@ | John@viridiantherapeutics.com.com |
| Pain Points | Locations | Technologies |
|---|---|---|
| Build & Release | United States | quality assurance, communication, e, sas, testing, audit, data analysis, operating procedures, compliance, acceptance testing, k, financial, sharepoint |
| Build & Release | Waltham, MA | networking, communication, e, continuous improvement, voice, compliance, lms, k, collaboration, scheduling, operations, financial, networking communication, sharepoint |
| CRM Implementation | Waltham, MA | networking, communication, e, continuous improvement, voice, compliance, k, financial, networking communication, sharepoint |
| Compliance | United States | quality assurance, communication, e, sas, testing, audit, data analysis, operating procedures, compliance, acceptance testing, k, financial, sharepoint |
| Compliance | Waltham, MA | networking, communication, e, continuous improvement, voice, compliance, k, financial, networking communication, sharepoint |
Viridian Therapeutics, Inc looking to hire in Application Development in Waltham, MA
Viridian Therapeutics, Inc looking to hire in Application Development in United States
Viridian Therapeutics, Inc looking to hire in Business process management in Waltham, MA
Azure
Collaborator
Gcp
Informatica
Netsuite
Acceptance testing
Accreditation
Analytics
Archival
Archiving
At Viridian, we are focused on developing best-in-class medicines for people living with autoimmu...
View MoreAt Viridian Therapeutics, we are focused on developing best-in-class medicines for people living ...
View MoreAt Viridian, we work with a sense of urgency for patients and are committed to using proven scien...
View MoreAt Viridian Therapeutics, we are focused on developing best-in-class medicines for people living ...
View MoreDouglas Tsao, an analyst from H.C. Wainwright, reiterated the Buy rating on Viridian Therapeutics. The associated price target remains the same with $34.00.
Read MoreThe biopharmaceutical sector has long been a battleground for innovation, but few partnerships in 2025 have sparked as much optimism as Viridian
Read MoreViridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridians expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. Viridians goal is to advance VRDN-001 as a potential...
Viridian therapeutics, inc operates in the Biotechnology research industry.
Viridian therapeutics, inc's revenue is $302.00k
Viridian therapeutics, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.